Mirum Pharmaceuticals (MIRM) Net Margin (2021 - 2026)
Mirum Pharmaceuticals (MIRM) posted quarterly Net Margin of 494.21% for Q1 2026, down 48106.0% year-over-year from N/an in Q1 2025, and down 12745.36% quarter-over-quarter from 3.85% in Q4 2025.
Powered by 
Analysis
Mirum Pharmaceuticals (MIRM) Net Margin (2021 - 2026) Analysis & Trends
Mirum Pharmaceuticals' Net Margin history runs 6 years deep, the most recent figure standing at 494.21% for Q1 2026.
- In Q1 2026, Net Margin fell 48106.0% year-over-year to 494.21%; the TTM figure through Mar 2026 stood at 140.24% (down 11985.0% YoY), while the FY2025 annual figure was 4.48%, up 2162.0% from the prior year.
- Net Margin for Q1 2026 stood at 494.21%, down from 3.85% in the prior quarter.
- The five-year high for Net Margin was 2.18% in Q3 2025, with the low at 494.21% in Q1 2026.
- The 5-year median for Net Margin is 49.42% (2023), against an average of 104.33%.
- Peak annual rise in Net Margin reached 75203 bps in 2022, while the deepest fall reached 195592 bps in 2022.
- Mirum Pharmaceuticals' Net Margin stood at 130.55% in 2022, then jumped by 61 bps to 51.27% in 2023, then surged by 53 bps to 23.93% in 2024, then soared by 84 bps to 3.85% in 2025, then sank by 12745 bps to 494.21% in 2026.
- Business Quant data shows MIRM's Net Margin at 494.21% in Q1 2026, 3.85% in Q4 2025, and 2.18% in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 32.99% |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 30.23% |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | 31.16% |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | -539.31% |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 13.90% |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 12.74% |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 12.09% |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | -3.12% |
| 10 | Mirum Pharmaceuticals | 6.40 Bn | 5.96 Bn | 145.90 Mn | -38.14% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -38.14% |
| Mar 31, 2026 | -494.21% |
| Dec 31, 2025 | -3.85% |
| Sep 30, 2025 | 2.18% |
| Jun 30, 2025 | -4.59% |
| Mar 31, 2025 | -13.15% |
| Dec 31, 2024 | -23.93% |
| Sep 30, 2024 | -15.75% |
| Jun 30, 2024 | -31.64% |
| Mar 31, 2024 | -36.52% |
| Dec 31, 2023 | -51.27% |
| Sep 30, 2023 | -49.42% |
| Jun 30, 2023 | -197.45% |
| Mar 31, 2023 | -95.35% |
| Dec 31, 2022 | -130.55% |
| Sep 30, 2022 | -190.13% |
| Jun 30, 2022 | -153.98% |
| Mar 31, 2022 | -283.94% |
| Dec 31, 2021 | 1,825.37% |
| Sep 30, 2021 | -942.16% |